Report post
Pfizer, a pharmaceutical giant, has announced its latest acquisition of cancer-drug Maker Seagen for a staggering $43 billion. This marks another significant takeover for Pfizer, following its successful Pfizer-Warner Lambert merger. The company's CEO boasts that 2022 was one of the most successful years in Pfizer's history, further solidifying its position as a leading player in the pharmaceutical industry. Learn more about Pfizer's acquisition strategy and its impact on the industry.

The World's Leading Crypto Trading Platform

Get my welcome gifts